Spectral Medical Inc T.EDT

Company and Stockhouse plants BS continues!!!!!!

[Stocktree]

Some apparently very happy folks this morning.

The truth: the company is lying. They say they still expect to complete the Tigris trial in 2022.
They currently have 15 patients randomized over 150.
They  announced the trial was approved in Feb. 2019. That is over 2 years for a tenth of the population required.

So multiply that 2 years by 10 and... while I don't expect this trial to end in 18 years, there is no way it will be completed in 2022.

And as for the company's history with information like "we are very happy with the data":
that's a big fat PASS.

If they had started packing a profit with what they already have in hand and fits perfectly with the health crisis we are in, I would be slightly less pessimistic about them. But I do not believe a second today's news will attract some big players, however you spin it with exclamation marks and, down the road fake innuendos wrapped in pumping BS.

[Rickkie]

Stocktree, why are they lying? Does anyone benefit from the lying and if so how?  ======================================================= Some apparently very happy folks this morning. The truth: the company is lying. They say they still expect to complete the Tigris trial in 2022. They currently have 15 patients randomized over 150. They  announced the trial was approved in Feb. 2019

[Stocktree]

I don't really care why they are doing or not doing anything. But they have misled and screwed us more than once. So until the SP takes an unexpected upward tangent because some market maker makes a move or this company actually takes advantage of the market opportunities to the level it should and accelerates its Tigris trial and has it approved and THEN sell their procedure AND makes all of